Full name
"LABORATORIUM DIAGNOSTYKI MOLEKULARNEJ" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
"LABORATORIUM DIAGNOSTYKI MOLEKULARNEJ" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. GLINIANA 40A, 50-525 WROCŁAW
TAX ID8971706439
Rate company:
"LABORATORIUM DIAGNOSTYKI MOLEKULARNEJ" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID8971706439
KRS0000238115
Share capital100,000.00 zł
address
UL. GLINIANA 40A, 50-525 WROCŁAW
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
8971706439
REGON
020103687
KRS
0000238115
Legal form
limited liability company
Register Address
UL. GLINIANA 40A, 50-525 WROCŁAW
Date of registration in KRS
2005-07-19
Date of commencement of economic activity
2005-07-19
Act signature
RDF/657776/24/946
Pkd codes
86.90.E - Other human health activities notelsewhere classified
68.20.Z - Rental and operating of own or leased real estate
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
Payer VAT status
exempted
Vat list bank account(s)
PL23 9575 1027 0000 1034 2000 0010 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | 304,7 | 76,4 | 86,7 | 13,5 |
EBITDA | 326,6 | 125,2 | 129,4 | 3,3 |
Short time liabilities | 35,8 | 36,3 | 38,5 | 6 |
Equity capital | 347,4 | 368,3 | 407,8 | 10,7 |
Operating profit (EBIT) | 306 | 77,6 | 86,9 | 11,9 |
Assets | 383,4 | 404,6 | 446,3 | 10,3 |
Net profit (loss) | 274,8 | 68,3 | 77,8 | 13,9 |
Cash | 257,8 | 339,9 | 397,4 | 16,9 |
Net income from sale | 716 | 451 | 530,3 | 17,6 |
Liabilities and provisions for liabilities | 36,1 | 36,3 | 38,5 | 6 |
Working assets | 287,4 | 356,2 | 440,3 | 23,6 |
Depreciation | 20,6 | 47,6 | 42,5 | -10,8 |
% | % | % | p.p. | |
Profitability of capital | 79,1 | 18,5 | 19,1 | 0,6 |
Equity capital to total assets | 90,6 | 91 | 91,4 | 0,4 |
Gross profit margin | 42,6 | 16,9 | 16,3 | -0,6 |
EBITDA Margin | 45,6 | 27,8 | 24,4 | -3,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 18 | 29 | 26 | -3 |
Current financial liquidity indicator | 7.969870567321777 | 9.808452606201172 | 11.439238548278809 | 1,6 |
Net dept to EBITDA | -0.789405882358551 | -2.7136666774749756 | -3.0714528560638428 | -0,4 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Gabinet Terapeutyczny Piotr Gumienny
Warszawa
PRACOWNIA PSYCHOLOGICZNA AGAMED mgr Agnieszka Piecuch
TARNOWSKIE GÓRY